SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-18-002548
Filing Date
2018-09-18
Accepted
2018-09-18 06:01:33
Documents
3
Period of Report
2018-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1822104.htm 8-K 19167
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 262964
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 11317
  Complete submission text file 0001178913-18-002548.txt   294694
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 181074573
SIC: 2833 Medicinal Chemicals & Botanical Products